United States · FDA National Drug Code directory
acamprosate calcium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70771-1057_c9752e78-2bf3-4e62-a947-a3d7fe757a1b
- Product NDC
- 70771-1057
- Form
- TABLET, DELAYED RELEASE
- Composition / generic term
- acamprosate calcium
- Labeler
- Zydus Lifesciences Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170601
- Source listing expiry
- 20261231
Source-listed ingredients
- ACAMPROSATE CALCIUM — 333 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 TABLET, DELAYED RELEASE in 1 BOTTLE (70771-1057-0) · 70771-1057-0
- 100 TABLET, DELAYED RELEASE in 1 BOTTLE (70771-1057-1) · 70771-1057-1
- 30 TABLET, DELAYED RELEASE in 1 BOTTLE (70771-1057-3) · 70771-1057-3
- 500 TABLET, DELAYED RELEASE in 1 BOTTLE (70771-1057-5) · 70771-1057-5
- 180 TABLET, DELAYED RELEASE in 1 BOTTLE (70771-1057-8) · 70771-1057-8
- 90 TABLET, DELAYED RELEASE in 1 BOTTLE (70771-1057-9) · 70771-1057-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →